Predictive Oncology Inc. announced the appointment of Marc Malandro, Ph.D., to the company's Scientific Advisory Board where he will serve alongside other key thought leaders in their respective fields to guide the company's scientific initiatives and growth strategy. A highly regarded scientific leader with significant experience in business, law and philanthropy, Dr. Malandro currently serves as the Vice President of Operations for Science at the Chan Zuckerberg Initiative, where he is part of the team that partners, supports and builds novel advances and tools to enable and accelerate biomedical research. As an expert in genomics, molecular biology, biochemistry and bioengineering, Dr. Malandro has held roles in both business and corporate settings.

Prior to Chan Zuckerberg Initiative, he was Vice Chancellor for Technology Management and Commercialization and the Founding Director of the Innovation Institute at the University of Pittsburgh. Prior to that, Dr. Malandro co-founded Sagres Discovery, a systems biology company focused on the understanding of the molecular basis of cancer, where he served as Vice President of Technology and Strategic Alliances. There he was involved in all aspects of intellectual property, licensing and alliance management.